Company
SGX:Q0F
Operates a private hospital network of 89 hospitals across 10 countries (Malaysia, Singapore, Turkiye, India, China, Hong Kong, Brunei, Bulgaria, North Macedonia, Netherlands, Serbia), including the Mount Elizabeth, Gleneagles and Parkway brands in Singapore. Its longevity relevance is delivery-side rather than therapeutic: it is the largest listed vehicle for age-related clinical care in Asia, with revenue concentrated in cardiology, oncology and orthopaedics, the specialties that scale with an ageing population. It also runs an SGD 80 million innovation fund backing startups in cancer diagnostics, digital health, proton therapy, mental health and sleep disorders. It does not develop geroprotective drugs or biological-age interventions. Inclusion is confirmed under limb (a): SGX secondary line Q0F verified on a live SGX healthcare sector listing.
Thesis
Market data
| Metric | Detail |
|---|---|
| Exchange | SGX |
| Ticker | SGX:Q0F |
| Secondary listing | Bursa Malaysia (primary listing, IHH) |
| Market cap | Not disclosed |
| Status | Listed and trading |
Get in touch
Offering
No commercial services are recorded for this company yet.
People
variis does not publish portraits of named individuals without a licence to do so.
Recent inflection
13 July 2026: IHH set out a scaled-up India programme via its Fortis Healthcare subsidiary, targeting 10,000 beds by 2030 (roughly 8,000 visible through brownfield expansion), naming India as a global business services hub, and directing its SGD 80 million innovation fund toward AI, precision medicine and advanced oncology technology. Reported by Business Today.
Keep reading
Sources
Every entity profile on variis is sourced. Not investment advice.